[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
D004295:Dihydroxyphenylalanine / Q000628:therapy*; D006801:Humans; D007444:Inulin / Q000031:analogs & derivatives; D010300:Parkinson Disease / Q000628:therapy*
C010200:inulin trinicotinate monomethochloride; D004295:Dihydroxyphenylalanine; D007444:Inulin
DOPA/therapy; PARALYSIS AGITANS/therapy